O

    Opko Health Inc (OPK)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $1.47
    -0.01 (-0.68%)

    Market Cap: $1.10B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    68%(27/40)
    Avg Surprise
    -5.62%
    Streak
    9 Q

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$-0.07
    Range$-0.08 - $-0.06
    2 analysts
    EPS Revisions
    1
    0
    7d
    1
    0
    30d
    EPS Estimate Drift
    90d ago$-0.11-57.1%
    60d ago$-0.11-57.1%
    30d ago$-0.11-57.1%
    7d ago$-0.07+0.0%
    Current$-0.07
    Revenue Consensus
    $137M
    Range$135M - $138M
    6 analysts
    Dec 31, 2026
    EPS Consensus$0.03
    Range$0.03 - $0.03
    1 analysts
    Revenue Consensus
    $171M
    Range$168M - $174M
    6 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$0.03---
    Sep 26EST
    		-$-0.07---
    Jun 26
    		$-0.01N/A+87.50%Beat+87.5%
    Mar 26
    		$-0.07$-0.07+0.00%Beat+22.2%
    Dec 25
    		$-0.04$-0.07+42.86%Beat-500.0%
    Sep 25
    		$0.03$-0.04+175.00%Beat+0.0%
    Jun 25
    		$-0.08$-0.10+20.00%Beat-700.0%
    Mar 25
    		$-0.09$-0.11+18.18%Beat+25.0%
    Dec 24
    		$0.01N/A+110.00%Beat+111.1%
    Sep 24
    		$0.03N/A+133.33%Beat+127.3%
    Jun 24
    		$-0.01N/A+88.89%Beat+66.7%
    Mar 24
    		$-0.12$-0.09-33.33%Miss-500.0%
    Dec 23
    		$-0.09$-0.09+0.00%Beat+18.2%
    Sep 23
    		$-0.11$-0.10-10.00%Miss+0.0%
    Jun 23
    		$-0.03N/A+57.14%Beat+78.6%
    Mar 23
    		$-0.02N/A+75.00%Beat+75.0%
    Dec 22
    		$-0.11$-0.11+0.00%Beat+0.0%
    Sep 22
    		$-0.11$-0.08-37.50%Miss-375.0%
    Jun 22
    		$-0.14$0.03-566.67%Miss-366.7%
    Mar 22
    		$-0.08$-0.06-33.33%Miss-260.0%
    Dec 21
    		$-0.11$-0.02-450.00%Miss-320.0%
    Sep 21
    		$0.04$-0.01+500.00%Beat+0.0%
    Jun 21
    		$-0.03$0.02-250.00%Miss-160.0%
    Mar 21
    		$0.05$0.05+0.00%Beat+155.6%
    Dec 20
    		$0.05$0.04+25.00%Beat+127.8%
    Sep 20
    		$0.04$0.04+0.00%Beat+136.4%
    Jun 20
    		$0.05$-0.07+171.43%Beat+145.5%
    Mar 20
    		$-0.09$-0.09+0.00%Beat+30.8%
    Dec 19
    		$-0.18$-0.09-100.00%Miss-100.0%
    Sep 19
    		$-0.11$-0.09-22.22%Miss-120.0%
    Jun 19
    		$-0.11$-0.11+0.00%Beat-266.7%
    Mar 19
    		$-0.13$-0.11-18.18%Miss-62.5%
    Dec 18
    		$-0.09$-0.09+0.00%Beat+71.9%
    Sep 18
    		$-0.05$-0.06+16.67%Beat+37.5%
    Jun 18
    		$-0.03N/A+57.14%Beat+0.0%
    Mar 18
    		$-0.08$-0.13+38.46%Beat-33.3%
    Dec 17
    		$-0.32$-0.08-300.00%Miss-1500.0%
    Sep 17
    		$-0.08$-0.05-60.00%Miss-300.0%
    Jun 17
    		$-0.03$-0.05+40.00%Beat-
    Mar 17
    		$-0.06$-0.04-50.00%Miss-
    Dec 16
    		$-0.02$-0.04+50.00%Beat-
    Sep 16
    		$-0.02$-0.02+0.00%Beat-

    Key Metrics

    Valuation
    P/E Ratio-16.33EV/EBITDA22.10x
    Price/FCF-8.28xFCF Yield-12.07%
    Profitability
    Profit Margin-12.40%Operating Margin-15.30%
    ROE-5.88%ROIC1.71%
    Financial Health
    Debt/Equity0.29xInterest Coverage0.60x
    Current Ratio3.35xQuick Ratio2.93x
    Trading Statistics
    Beta1.49Avg Volume2.63M
    52-Week High$1.7352-Week Low$0.98

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.47
    SMA 20$1.42
    SMA 50$1.38
    SMA 200$1.29
    EMA 10$1.46
    EMA 20$1.43
    EMA 50$1.38
    EMA 200$1.33

    MACD

    Line: 0.04Signal: 0.03Hist: 0.01

    ADX

    ADX: 39.6+DI: 27.9-DI: 13.2

    Aroon & PSAR

    Aroon Up4.0
    Aroon DownN/A
    PSAR$1.38

    Bollinger Bands

    Upper Band$1.54
    Lower Band$1.29
    %B Position1798%(Upper)
    Band Width0.71

    RSI (14-Day)

    Neutral
    57.9

    Momentum Oscillators

    Stoch %K77.8
    Stoch %D84.0
    Williams %R-28.6
    ROC (10d)8.1%
    Momentum0.11
    CCI (20d)66.1
    MFI (14d)68.5

    Volatility Measures

    ATR (14d)$0.06(4.1%)
    StdDev (20d)0.06
    Hist Vol34.4%(Moderate)

    Volume Flow

    VWAP$1.47
    OBV45.3M
    AD Line-46.9M
    CMF (20d)0.059

    Volume Metrics

    Avg Vol (20d)2.5M
    Vol Ratio0.9x
    VWMA (20d)$1.42

    Pivot Points

    R3$1.54
    R2$1.52
    R1$1.50
    Pivot Point$1.48
    S1$1.46
    S2$1.44
    S3$1.42

    Advanced Oscillators

    TSI16.93
    Ultimate Osc49.2
    KST93.57

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$163.58M$124.20M$148.45M$151.67M$156.81M$149.95M$183.64M$173.63M$182.19M$173.69M$181.91M$178.59M
    Cost of Revenue$83.56M$78.44M$84.43M$101.78M$107.41M$107.33M$98.98M$133.50M$130.53M$131.62M$137.20M$130.92M
    Gross Profit$80.02M$45.76M$64.03M$49.89M$49.40M$42.62M$84.66M$40.13M$51.65M$42.07M$44.71M$47.68M
    Operating Expenses$86.99M$96.77M$102.34M$1.84M$109.38M$109.79M$117.80M$25.91M$113.32M$113.54M$113.75M$112.08M
    R&D$33.17M$29.20M$32.77M$30.08M$30.34M$30.84M$30.43M$28.77M$24.08M$21.94M$19.39M$19.43M
    SG&A$52.92M$48.61M$50.52M$53.80M$59.60M$59.09M$67.03M$98.20M$68.82M$70.17M$72.88M$72.24M
    Operating Income$-6,972,000$-51,017,000$-38,316,000$48.06M$-59,981,000$-67,168,000$-33,139,000$14.22M$-61,670,000$-71,472,000$-69,045,000$-64,407,000
    Interest Income$3.22M$3.01M$3.82M$3.02M$3.29M$4.68M$4.29M$2.93M$391,000$813,000$906,000$970,000
    Interest Expense$11.38M$10.94M$11.31M$11.36M$70.33M$15.47M$14.24M$17.36M$8.18M$7.69M$3.45M$3.38M
    Income Before Tax$-13,399,000$-60,956,000$-46,901,000$41.43M$-162,520,000$-73,374,000$34.98M$48.42M$-10,584,000$-83,183,000$-72,494,000$-78,378,000
    Income Tax Expense$-4,983,000$-6,110,000$-15,661,000$19.80M$-14,079,000$-5,770,000$20.95M$23.53M$-280,000$-1,350,000$-6,019,000$6.08M
    Net Income$-8,416,000$-54,848,000$-31,257,000$21.63M$-148,441,000$-67,613,000$14.03M$24.89M$-10,305,000$-81,836,000$-66,483,000$-84,473,000
    EBITDA$17.31M$-30,686,000$-16,900,000$72.64M$-67,924,000$-38,672,000$69.62M$87.40M$21.79M$-49,971,000$-43,650,000$-49,332,000
    EBIT$-5,240,000$-53,024,000$-39,410,000$49.77M$-95,480,000$-62,589,000$44.93M$62.85M$-2,795,000$-76,310,000$-69,946,000$-75,964,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about OPK

    Government Contracts

    Gov Obligations (TTM)
    -$180092
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    N/A
    Active Awards
    1
    New Awards (TTM)
    0
    Avg Remaining Term
    N/A

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    AWM Investment Company Inc. Makes New Investment in OPKO Health, Inc. $OPK

    AWM Investment Company Inc. recently acquired a new stake of 2,110,000 shares in OPKO Health, Inc. (NASDAQ:OPK), valued at approximately $3,165,000. This investment makes AWM Investment Company Inc. an owner of about 0.28% of OPKO Health. Other institutional investors also made new investments in OPKO Health, and the company has received a consensus "Hold" rating from analysts with a target price of $1.55.

    MarketBeat•8/26/26•
    Neutral

    OPKO Health (OPK) Upgraded to Buy: Here's What You Should Know

    OPKO Health (OPK) has been upgraded to a Zacks Rank #2 (Buy) due to an upward trend in earnings estimates. This upgrade suggests a positive outlook for the company's earnings, which historically correlates strongly with stock price movements. The Zacks Rank system, which uses earnings estimate revisions, aims to identify stocks with the potential for market-beating returns.

    Eastern Progress•8/23/26•
    Bullish

    OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going?

    OPKO Health, Inc. (OPK) shares have risen 12.4% in the last month, driven by narrower operating losses, improved margins, and favorable estimate revisions. While the company remains unprofitable, its future upside depends on clinical pipeline execution and progress at BioReference. Despite a mixed broader outlook, OPK's recent momentum is supported by its strong Momentum Score, though other style scores are less favorable.

    TradingView•8/20/26•
    Somewhat-Bullish

    OPK Raises $125 Million Against Royalties: What Investors Should Know

    OPKO Health (OPK) has secured an additional $125 million in financing by leveraging future royalties from its mazdutide license agreement with Eli Lilly and Company (LLY). This non-dilutive funding, structured as senior secured notes maturing in 2044, provides capital for OPK's extensive clinical pipeline and operating needs without issuing new equity. While it offers immediate liquidity, the company retains exposure to future royalty growth in China, but still faces execution risks associated with its pipeline and diagnostics business.

    Yahoo Finance•8/20/26•
    Neutral

    OPK Climbs 12.4% in the Past Month: Can the Stock Rally Keep Going?

    OPKO Health (OPK) shares have risen 12.4% over the past month, driven by narrower operating losses, improved margins, and favorable estimate revisions. While the company remains loss-making, its BioReference division has turned profitable, and pharmaceutical revenues have significantly increased. Upcoming clinical milestones for ModeX and other candidates in late 2026 or early 2027 could further support the stock, though profitability and execution risks remain.

    Eastern Progress•8/19/26•
    Somewhat-Bullish

    Frequently Asked Questions About OPK

    Does OPK pay dividends?
    Opko Health Inc (OPK) does not currently pay a regular dividend.
    What is OPK's market cap?
    Opko Health Inc (OPK) has a market capitalization of $1.10B with a current stock price of $1.47.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In